Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 4/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.45 |
| ▸ | MAPT | P10636 | 3/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.45 |
| ▸ | HTT | P42858 | 3/20 | 0.45 |
| ▸ | HPGD | P15428 | 4/20 | 0.43 |
| ▸ | LMNA | P02545 | 3/20 | 0.43 |
| ▸ | CRHBP | P24387 | 1/20 | 0.43 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 3/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3745809 | 1.00 | CA1 (0.50) | CA1CA2MEN1KMT2AMAPK1 | |
| SCHEMBL23972664 | 0.82 | ALDH1A1 (0.48) | MEN1KMT2AMAPK1LMNATSHR | |
| SCHEMBL31435516 | 0.81 | CES2 (0.46) | CA1CA2MAPK1LMNATSHR | |
| SCHEMBL23973184 | 0.81 | CES2 (0.46) | CA1CA2MAPK1LMNATSHR | |
| SCHEMBL6591473 | 0.79 | PTGS2 (0.57) | CA1CA2MEN1KMT2AMAPK1 | |
| SCHEMBL8622029 | 0.79 | MEN1 (0.54) | CA1CA2MEN1KMT2AMAPK1 | |
| SCHEMBL5159165 | 0.78 | TSHR (0.48) | MEN1KMT2AMAPK1NPSR1HTT | |
| SCHEMBL1513247 | 0.78 | TSHR (0.48) | MEN1KMT2AMAPK1NPSR1HTT | |
| SCHEMBL10456166 | 0.78 | BLM (0.59) | MEN1KMT2AMAPK1MAPTNPSR1 | |
| Hydrochloric Acid SCHEMBL8617929 | 0.78 | MEN1 (0.53) | CA1CA2MEN1KMT2AMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2029515-B1 | USE OF METAL COMPLEXES COMPRISING A LIGAND DERIVED FROM 2-ARYL-2-HYDROXYACETIC ACID AND A DIVALENT OR TRIVALENT METAL CATION FOR THE TREATMENT OF METAL DEFICIENCY IN PLANTS. | WEYLCHEM LAMOTTE (FR) | 2016-03-09 | — | — | EP | disclosed |
| EP-2029515-B1 | USE OF METAL COMPLEXES COMPRISING A LIGAND DERIVED FROM 2-ARYL-2-HYDROXYACETIC ACID AND A DIVALENT OR TRIVALENT METAL CATION FOR THE TREATMENT OF METAL DEFICIENCY IN PLANTS. | WEYLCHEM LAMOTTE (FR) | 2016-03-09 | — | — | EP | disclosed |
| US-8372176-B2 | Metal complexes comprising a ligand derived from 2-aryl-2-hydroxyacetic acid and a divalent or trivalent metal cation, and their use | CLARIANT SPECIALTY FINE CHEMICALS (FRANCE) (FR) | 2013-02-12 | — | — | US | disclosed |
| US-8372176-B2 | Metal complexes comprising a ligand derived from 2-aryl-2-hydroxyacetic acid and a divalent or trivalent metal cation, and their use | CLARIANT SPECIALTY FINE CHEMICALS (FRANCE) (FR) | 2013-02-12 | — | — | US | disclosed |
| US-8372176-B2 | Metal complexes comprising a ligand derived from 2-aryl-2-hydroxyacetic acid and a divalent or trivalent metal cation, and their use | CLARIANT SPECIALTY FINE CHEMICALS (FRANCE) (FR) | 2013-02-12 | — | — | US | disclosed |
| CN-102603368-A | Metal complexes comprising ligands derived from 2-aryl-2-hydroxyacetic acid and divalent or trivalent metal cations and use thereof | CLARIANT SPECIALTY FINE CHEM F | 2012-07-25 | — | — | CN | disclosed |
| CN-101454268-B | Metal complexes comprising ligands derived from 2-aryl-2-hydroxyacetic acid and divalent or trivalent metal cations and use thereof | CLARIANT SPECIALTY FINE CHEM | 2012-07-11 | — | — | CN | disclosed |
| US-20100288004-A1 | Metal Complexes Comprising A Ligand Derived From 2-Aryl-2-Hydroxyacetic Acid And A Divalent Or Trivalent Metal Cation, And Their Use | CLARIANT SPECIALTY FINE CHEMICALS (FRANCE) (FR) | 2010-11-18 | — | — | US | disclosed |
| US-20100288004-A1 | Metal Complexes Comprising A Ligand Derived From 2-Aryl-2-Hydroxyacetic Acid And A Divalent Or Trivalent Metal Cation, And Their Use | CLARIANT SPECIALTY FINE CHEMICALS (FRANCE) (FR) | 2010-11-18 | — | — | US | disclosed |
| US-20100288004-A1 | Metal Complexes Comprising A Ligand Derived From 2-Aryl-2-Hydroxyacetic Acid And A Divalent Or Trivalent Metal Cation, And Their Use | CLARIANT SPECIALTY FINE CHEMICALS (FRANCE) (FR) | 2010-11-18 | — | — | US | disclosed |
| CN-101454268-A | Metal complexes comprising ligands derived from 2-aryl-2-hydroxyacetic acid and divalent or trivalent metal cations and use thereof | CLARIANT SPECIALTY FINE CHEM (FR) | 2009-06-10 | — | — | CN | disclosed |
| EP-2029515-A1 | METAL COMPLEXES COMPRISING A LIGAND DERIVED FROM 2-ARYL-2-HYDROXYACETIC ACID AND A DIVALENT OR TRIVALENT METAL CATION, AND THEIR USE | Clariant Specialty Fine Chemicals (France) (FR) | 2009-03-04 | — | — | EP | disclosed |
| WO-2007135109-A1 | METAL COMPLEXES COMPRISING A LIGAND DERIVED FROM 2-ARYL-2-HYDROXYACETIC ACID AND A DIVALENT OR TRIVALENT METAL CATION, AND THEIR USE | CLARIANT SPECIALTY FINE CHEMICALS (FRANCE) (FR) | 2007-11-29 | — | — | WO | disclosed |
| WO-2007135109-A1 | METAL COMPLEXES COMPRISING A LIGAND DERIVED FROM 2-ARYL-2-HYDROXYACETIC ACID AND A DIVALENT OR TRIVALENT METAL CATION, AND THEIR USE | CLARIANT SPECIALTY FINE CHEMICALS (FRANCE) (FR) | 2007-11-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100288004-A1 | Metal Complexes Comprising A Ligand Derived From 2-Aryl-2-Hydroxyacetic Acid And A Divalent Or Trivalent Metal Cation, And Their Use | HACL2, HAO2, HCAR2 | CA1 1077/4885CA2 54/4885MEN1 4033/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.